Literature DB >> 6765971

Activation of human complement by heat-killed, human kidney cells grown in cell culture.

P J Baker, S G Osofsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6765971

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement.

Authors:  J L Abkowitz; R D Holly; C K Grant
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.

Authors:  B Jahn; J Von Kempis; K L Krämer; S Filsinger; G M Hänsch
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

3.  Preferential activation and depletion of the alternative complement pathway by burn injury.

Authors:  J A Gelfand; M Donelan; J F Burke
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

4.  Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.

Authors:  P J Baker; S G Osofsky
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

5.  Recurrent pyogenic infections in individuals with absence of the second component of complement.

Authors:  H A Sampson; A M Walchner; P J Baker
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

6.  Alternative complement pathway activation increases mortality in a model of burn injury in mice.

Authors:  J A Gelfand; M Donelan; A Hawiger; J F Burke
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

Review 7.  Therapeutic uses of recombinant complement protein inhibitors.

Authors:  K R Kalli; P Hsu; D T Fearon
Journal:  Springer Semin Immunopathol       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.